Truncation artifact on PET/CT: Impact on measurements of activity concentration and assessment of a correction algorithm

American Journal of Roentgenology

Volumn 186, Issue 5, 2006, Pages 1458-1467

  Mawlawi, Osama ^a   Erasmus, Jeremy J ^a   Pan, Tinsu ^a   Cody, Dianna D ^a   Campbell, Rachelle ^a   Lonn, Albert H ^b   Kohlmyer, Steve ^b   Macapinlac, Homer A ^a   Podoloff, Donald A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b GE HEALTHCARE   (United States)

Author keywords

Attenuation correction; Nuclear medicine; Oncologic imaging; PET CT; Truncation artifact

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; ARTIFACT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MALE; MEASUREMENT; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION ATTENUATION; IMAGE QUALITY; MIDDLE AGED;

ADULT; AGED; ALGORITHMS; ARTIFACTS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33745515808     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.05.0255     Document Type: Article

References (23)

1. Bury T, Barreto A, Daenen F, Barthelemy N, Ghaye B, Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1998; 25:1244-1247
2. van Tinteren H, Hoekstra OS, Smit EF, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002; 359:1388-1393
3. Cerfolio RI, Ojha B, Mukherjee S, Pask AH, Bass CS, Katholi CR. Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma. J Thorac Cardiovasc Surg 2003; 125:938-944
4. Weber WA, Petersen V, Schmidt B, et al. Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use. J Clin Oncol 2003; 21:2651-2657
5. 18F-FDG PET evaluation of the response to therapy for lymphoma and for breast, lung, and colorectal carcinoma. J Nucl Med 2003; 44:224-239
6. Reed CE, Harpole DH, Posther KE, et al. Results of the American College of Surgeons Oncology Group Z0050 trial; the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg 2003; 126:1943-1951
7. Pieterman RM, van Putten JW, Meuzelaar JJ, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 2000; 343:254-261
8. Pelosi E, Messa C, Sironi S, et al. Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study. Eur J Nucl Med Mol Imaging 2004; 31:932-939
9. Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348:2500-2507
10. Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology 2003; 229:526-533
11. Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys 1998; 25:2046-2053
12. Beyer T, Antoch G, Blodgett T, Freudenberg LF, Akhurst T, Mueller S. Dual-modality PET/CT im aging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 2003; 30:588-596
13. Kluetz PG, Meltzer CC, Villemagne VL, et al. Combined PET/CT imaging in oncology: impact on patient management. Clin Positron imaging 2000; 3:223-230
14. Hsieh J, Chao E, Thibault J, et al. A novel reconstruction algorithm to extend the CT scan field of view. Med Phys 2004; 31:2385-2391
15. Carney J, Beyer T, Yap JT, Townsend DW. CT-based attenuation correction for PET/CT scanners. In: Schulthess GKV, ed. Clinical molecular anatomic imaging: PET, PET/CT, and SPECT/CT. Philadelphia, PA: Lippincott Williams & Wilkins, 2003:51-58
16. Ohnesorge B, Rohr T, Schwarz K, Heiken JP, Bae KT. Efficient correction for CT image artifacts caused by objects extending outside the scan field of view. Med Phys 2000; 27:39-46
17. Lonn AH, Hsieh J, Steans CW, Chao EH, Gerkowicz B. Evaluation of extension of the CT attenuation map in PET/CT. (abstr) J Nucl Med 2003; 44:39P
18. Mawlawi O, Podoloff DA., Kohlmyer S, et al. Performance characteristics of a newly developed PET/CT scanner using NEMA standards in 2D and 3D modes. J Nucl Med 2004; 45:1734-1742
19. Stearns CW, Fessler JA. 3D PET reconstruction with FORE & WLS-OS-EM. Proceedings of the IEEE Nuclear Science Symposium and Medical Imaging Conference. [CD-ROM]
20. Nakamoto Y, Osman M, Cohade C, et al. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl Med 2002; 43:1137-1143
21. Goerres GW, von Schulthess GK, Steinert HC. Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med 2004; 45[suppl 1]:66S-71S
22. Osman MM, Cohade C, Nakamoto Y, Wahl RL. Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT. Eur J Nucl Med Mol Imaging 2003; 30:603-606
23. Erasmus JJ, Truong MT, Mawlawi O. PET/CT of the thorax: techniques and pitfalls. In: McAdams HP and Reddy GP, eds. Cardiopulmonary imaging: categorical course syllabus. Leesburg, VA; American Roentgen Ray Society, 2005:287-300